GB916139A - Quinazolone derivatives - Google Patents
Quinazolone derivativesInfo
- Publication number
- GB916139A GB916139A GB8625/61A GB862561A GB916139A GB 916139 A GB916139 A GB 916139A GB 8625/61 A GB8625/61 A GB 8625/61A GB 862561 A GB862561 A GB 862561A GB 916139 A GB916139 A GB 916139A
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- acetamido
- carbon atoms
- general formula
- resin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Abstract
Resin-drug complexes are formed by salt formation and adsorption on sulphonic or carboxylic acid cation exchange resins of heterocyclic bases of general formula <FORM:0916139/IV(a)/1> in which R and R1 represent hydrogen or alkyl with up to 5 carbon atoms. These complexes are formed, for example, by treating a suspension of the resin in distilled water with the base.ALSO:The invention comprises compounds of general formula <FORM:0916139/IV (b)/1> in which R and R1 are hydrogen or alkyl containing up to five carbon atoms, and pharmaceutically acceptable salts thereof including salts with cation exchange resins (see Group IV(a)). The compounds are prepared by reduction of the corresponding 6-nitro compounds, which are prepared by condensation of the appropriately substituted aniline with the appropriately substituted 2 - alkanamido-5-nitrobenzoic acids. 2 - Acetamido - 5 - nitrobenzoic acid is obtained by oxidation of 2-acetamido-5-nitrotoluene. The compounds possess muscle relaxing and antispasmodic properties, and may be administered alone or with a carrier suitable for oral or parenteral administration to human beings or animals, e.g. as tablets, capsules, elixirs, syrups or suspensions.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1369160A | 1960-03-09 | 1960-03-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB916139A true GB916139A (en) | 1963-01-23 |
Family
ID=21761215
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB8625/61A Expired GB916139A (en) | 1960-03-09 | 1961-03-09 | Quinazolone derivatives |
Country Status (2)
Country | Link |
---|---|
BE (1) | BE701871A (en) |
GB (1) | GB916139A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3414573A (en) * | 1962-06-27 | 1968-12-03 | Squibb & Sons Inc | Certain 3-alkylphenyl-quinazolones |
-
1961
- 1961-03-09 GB GB8625/61A patent/GB916139A/en not_active Expired
-
1967
- 1967-07-26 BE BE701871D patent/BE701871A/xx unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3414573A (en) * | 1962-06-27 | 1968-12-03 | Squibb & Sons Inc | Certain 3-alkylphenyl-quinazolones |
Also Published As
Publication number | Publication date |
---|---|
BE701871A (en) | 1968-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES370394A1 (en) | 11-substituted 5 11-dihydro-6h-pyrido(2 3-b)(1 4)benzodiazepin-6-ones | |
AR240830A2 (en) | Substituted naphthyridine-, quinoline- and benzoxazine- carboxylic acids as antibacterial agents andprocesses for their production | |
HUT43570A (en) | Process for preparing novel decahydroquinoline derivatives and their salts, as well as pharmaceutics comprising the derivatives | |
GB1055055A (en) | Improvements in or relating to 4-[1-lower alkyl piperidylidene-(4)]-9,10-dihydro-4h-benzo[4,5]-cyclohepta[1,2-b]thiophene derivatives | |
GB1062714A (en) | -ß-(4'-acyloxy-4'-piperidyl)-ketones | |
GB1173227A (en) | Amino-Isoquinolines | |
ES407319A1 (en) | Fused imidazolidine derivatives | |
GB916139A (en) | Quinazolone derivatives | |
DK384485A (en) | 1,6-NAPHTHYRIDINE DERIVATIVES WITH CARDILATING EFFECT | |
GB902659A (en) | A process for the production of a derivative of thebaine | |
ES405479A1 (en) | Benzodiazepin-2-ones | |
PT90302A (en) | METHOD FOR THE PREPARATION OF HETERO-TETRACYLIC ACID DERIVATIVES | |
ES529007A0 (en) | PROCEDURE FOR THE MANUFACTURE OF AMINATED DERIVATIVES OF PIRIDAZINE SUBSTITUTED IN POSITION 6 BY A HETERO-CYCLE OR ALICYCLE, ACTIVE ON THE CENTRAL NERVOUS SYSTEM. | |
GB1505849A (en) | 9,10-dihydroanthracen-9,10-imine derivatives | |
GB925723A (en) | Novel thebaine derivatives | |
ES2057110T3 (en) | USE OF ISOXAZOLINONES AS DRUGS WITH ACTION ON THE BRAIN. | |
SE8804696D0 (en) | DIOXAZOCINE DERIVATIVES THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM | |
ES2042727T3 (en) | 1,3,4,9-TETRAHYDROPYRAN (3,4-B) INDOL-1-ACETIC ACIDS. | |
GB1069716A (en) | Improvements in or relating to pyrido[3,4-b]indole derivatives | |
GB1010231A (en) | Substituted 3-phenyl-5-imino-4,5 dihydro-1,2,4-oxadiazoles, process for their manufacture and therapeutic compositions containing same | |
IE830685L (en) | Piperidine derivatives. | |
GB1082571A (en) | New heterocyclic amino compounds, their salts and a process for the preparation thereof | |
ES367158A1 (en) | Procedure for the preparation of 3-phenyl-imidazo-tiazol. (Machine-translation by Google Translate, not legally binding) | |
SE7708175L (en) | 4-BENZAZONE INTERVENTION | |
GB912085A (en) | Quinazolone derivatives |